Can Ficicioglu

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 4

Top Topics

Gestational Age

Cross Sectional

Fluorescence Imaging

Replacement Therapy

Top Venues

Orphanet journal of rare diseases

American journal of medical genetics. Part A

International journal of neonatal screening

This page only lists publications with an associated author ORCID identifier.

Publications

David S Millington, Can Ficicioglu
Addition of MPS-II to the Recommended Uniform Screening Panel in the United States. International journal of neonatal screening 8 (4) (2022)
Can Ficicioglu, Dena R Matalon, Nicole Luongo, Caitlin Menello, Tracy Kornafel, Andrew J Degnan
Diagnostic journey and impact of enzyme replacement therapy for mucopolysaccharidosis IVA: a sibling control study. Orphanet journal of rare diseases 15 (1) (2020)
Amanda Barone Pritchard, Alanna Strong, Can Ficicioglu
Persistent dyslipidemia in treatment of lysosomal acid lipase deficiency. Orphanet journal of rare diseases 15 (1) (2020)
Can Ficicioglu, Roberto Giugliani, Paul Harmatz, Nancy J Mendelsohn, Virginie Jego, Rossella Parini
Intrafamilial variability in the clinical manifestations of mucopolysaccharidosis type II: Data from the Hunter Outcome Survey (HOS). American journal of medical genetics. Part A 176 (2) (2017)